<DOC>
	<DOCNO>NCT00417729</DOCNO>
	<brief_summary>To compare effect acarbose versus glibenclamide treatment mean amplitude glyclemic excursion oxidative stress diabetes individual fail control glucose metformin therapy alone</brief_summary>
	<brief_title>Effects Acarbose Versus Glibenclamide MAGE Oxidative Stress Patients With Type 2 DM</brief_title>
	<detailed_description>This randomise open-label study conduct 2 medical center central part Taiwan . Type 2 diabetic outpatient eligible age 30-70 year , mono- dual oral antidiabetic drug least 3 month , glycated hemoglobin ( HbA1c ) value 7.0 % 11.0 % . Patients treated insulin drug promote weight loss , impaired renal ( serum creatinine concentration great 132.6 μmol/l ) liver ( AST ALT 2.5 time upper limit normal range ) function , history hemoglobinopathy chronic anemia , woman child-bearing potential without adequate contraception exclude . All patient provide informed consent enrol study . After 8-week period metformin monotherapy ( 500 mg t.i.d . ) , patient randomise add either acarbose glibenclamide . The dos acarbose glibenclamide 50 mg t.i.d . 2.5 mg t.i.d. , respectively , 4 week force-titrated 100 mg t.i.d . 5 mg t.i.d. , respectively , last 12 week . A complete 72 hour glucose monitor use continuous glucose monitoring ( CGM ) system meal tolerance test ( MTT ) 10-h overnight fasting perform randomisation end study . Morning urine sample collect measurement 8-iso prostaglandin F2α ( 8-iso PGF2α ) , commonly use parameter oxidative stress ( 13-14 ) . The primary objective change MAGE obtain CGM urinary excretion rate 8-iso PGF2α . The secondary objective include change HbA1c , lipid profile include total cholesterol , low-density lipoprotein cholesterol ( LDL-C ) , high-density lipoprotein cholesterol ( HDL-C ) , triglyceride , oxidize low-density lipoprotein ( ox-LDL ) , high-sensitivity C-reactive protein ( hs-CRP ) , total adiponectin , high-molecular weight ( HMW ) adiponectin .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>Patients may include clinical trial meet follow criterion : 1 . Male female outpatient ; 2 . Age 30 70 year ; 3 . Patients fail achieve glycemic control diet , exercise max . 2 OHA ; Hemoglobin A1c level 7.0 11.0 % V1 711.5 % V4 . 4 . Diagnosis diabetes mellitus minimum 3month period ; 5 . All patient give write informed consent ; 6 . For female patient childbearing potential , follow criterion apply : Using adequate contraception since last menses continue use adequate contraception clinical trial . Not lactate . Negative pregnancy test ( urine ) within 7 day prior first dose study medication . ( Note : inclusion criterion 6 apply menopausal female ) . Patients exclude clinical trial follow reason : 1 . Patients serum creatinine concentration great 132.6 mmol/L ( 1.5 mg/dL ) liver function impairment ( AST ALT 2.5 time upper limit normal range ) ; 2 . Patients laboratory test abnormality ( biochemistry , hematology , urinalysis ) , investigator 's opinion might confound clinical trial . However , patient hyperlipemia , elevate cholesterol triglyceride level , lipid metabolism disorder eligible ; 3 . Use chronic insulin therapy ; 4 . Patients medical condition could promote lactic acidosis , renal hepatic disease , unstable angina , congestive heart failure ( New York Heart Association Functional Classification III IV ) , chronic obstructive pulmonary disease , e.g . respiratory insufficiency , hypoxemic condition ; 5 . Patients history hypersensitivity metformin hydrochloride , glibenclamide acarbose ; 6 . Patients receive investigational drug within 30 day prior admission clinical trial ; 7 . Patients significant alcohol , drug medication abuse judged investigator .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Acarobse</keyword>
	<keyword>Metformin</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>Mean amplitude Glycemic Excursion</keyword>
	<keyword>Meal test</keyword>
</DOC>